国产91亚洲福利精品一区二区,国产综合成人久久大片91,国产成人精品久久综合,久久久91精品国产一区二区三区,91福利国产在线在线播放,91精品国产高清久久久久久91,91精品国产福利在线观看麻豆,国产免费一区二区三区在线观看

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當(dāng)前位置: 首頁 > ATCC代理 > VMM5A
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號(hào)
  • 創(chuàng)e慧谷42號(hào)樓B幢401室
VMM5A
VMM5A
規(guī)格:
貨期:
編號(hào):B167207
品牌:Mingzhoubio

標(biāo)準(zhǔn)菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 VMM5A
商品貨號(hào) B167207
Organism Homo sapiens, human
Tissue Melanoma, Lymph Node Metastasis
Cell Type Melanocyte
Product Format frozen
Morphology Epithelial-like
Culture Properties adherent
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease Melanoma, Stage IIIC; malignant
Age 81
Gender Male
Ethnicity Caucasian
Applications Drug screening
Development of targeted therapy
Development of combination therapy
Tumor vaccine development
Storage Conditions liquid nitrogen vapor phase
Images ATCC CRL-3226 Cell Micrograph
Derivation Derived from tumors taken from tumor-involved lymph nodes from patients at the University of Virginia
Clinical Data Primary Site: Right Posterior Shoulder; Metastatic Site: Lymph Node, Right Neck
Antigen Expression Positives: High VEGF-R2, Low GP100, Tyrosinase, Low MAGE-A1, MMP-1
HLA Typing A2.1,A1101,B39,B44, BW4,BW6,C7(17)DR7, DR8,DR11,DQ2,DQ7
Comments NRAS: wt
CDKN2A: wt
BRAF Mutation: V600E
APC Mutation
PDGFRA Mutation: D842V
PTEN Mutation: R173H 
more sensitive to BAY43-9006 (BRAF kinase inhibitor) and to
rapamycin (mTOR kinase inhibitor), compared to cell lines with wild-type B-Raf

Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing

Volumes are for a T-75 flask; Adjust accordingly

  1. Remove and discard the cell culture medium from the flask.
  2. Rinse the cell monolayer with Dulbecco’s PBS without calcium or magnesium and remove.
  3. Add 3 to 4 ml of the trypsin-EDTA solution, rotate flask to rinse cell monolayer, remove trypsin solution, and incubate at 37oC.
  4. Once the cells appear to be detached, add 10 ml of complete growth medium with a pipette to the cell suspension to inactivate the trypsin. Gently wash any remaining cells from the growth surface of the   flask. Check the  cells with the microscope to be sure that most (>95%) are single cells. If cell clusters are apparent, continue to disperse the cells with gentle pipetting.
  5. Subculture as necessary.
  6. Place the flask back into the incubator. Examine the culture the following day to ensure the cells have reattached and are actively growing.
  7. Repeat when cells reach confluence.
Cryopreservation Fetal bovine serum, 90%; DMSO, 10%
Culture Conditions Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2 ), 5%
STR Profile Amelogenin: X,Y
D5S818: 9
D7S820: 9,10
D13S317: 12
D16S539: 12
vWA: 16
TH01: 9.3
TPOX: 8,11
CSF1PO: 11
Sterility Tests

Pass

Name of Depositor Craig L. Slingluff, Jr. M.D.
Passage History Unknown. 2 passages from 2003 frozen cell line stock, but it is not known how long the line was in culture after being established from tumor tissue obtained in 1992.
Year of Origin 1992
References

Slingluff C, et al. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunol. Immunother. 48:661-672, 2000. PubMed: 10752474

Molhoek K, et al. Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2. Cancer Res. 68: (11), 2008. PubMed: 18519701

Molhoek K, et al. Comprehensive analysis of RTK activation in human melanomas reveals autocrine signaling through IGF-1R. Melanoma Res 21(4): 274–284, 2011. PubMed: 21654344

Molhoek K, et al. Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin. J. Trans. Med. 3(39): 2005. PubMed:16255777

梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479
扎兰屯市| 繁昌县| 奉化市| 定安县| 大关县| 华容县| 上虞市| 瑞金市| 凌云县| 凤阳县| 灌南县| 张家口市| 石景山区| 许昌市| 喀喇沁旗| 郯城县| 鱼台县| 卢氏县| 治多县| 岫岩| 威海市| 杨浦区| 家居| 额济纳旗| 赤水市| 讷河市| 沐川县| 兴业县| 衢州市| 新建县| 丹江口市| 固原市| 夹江县| 绩溪县| 黑龙江省| 会宁县| 电白县| 礼泉县| 凤翔县| 体育| 漳浦县|